Literature DB >> 26858908

Spheroid Formation and Evaluation of Hepatic Cells in a Three-Dimensional Culture Device.

Yoshitaka Miyamoto1, Masashi Ikeuchi2, Hirofumi Noguchi3, Tohru Yagi4, Shuji Hayashi5.   

Abstract

In drug discovery, it is very important to evaluate liver cells within an organism. Compared to 2D culture methods, the development of 3D culture techniques for liver cells has been successful in maintaining long-term liver functionality with the formation of a hepatic-specific structure. The key to performing drug testing is the establishment of a stable in vitro evaluation system. In this article, we report a Tapered Stencil for Cluster Culture (TASCL) device developed to create liver spheroids in vitro. The TASCL device will be applied as a toxicity evaluation system for drug discovery. The TASCL device was created with an overall size of 10 mm × 10 mm, containing 400 microwells with a top aperture (500 µm × 500 µm) and a bottom aperture (300 µm diameter circular) per microwell. We evaluated the formation, recovery, and size of HepG2 spheroids in the TASCL device. The formation and recovery were both nearly 100%, and the size of the HepG2 spheroids increased with an increase in the initial cell seeding density. There were no significant differences in the sizes of the spheroids among the microwells. In addition, the HepG2 spheroids obtained using the TASCL device were alive and produced albumin. The morphology of the HepG2 spheroids was investigated using FE-SEM. The spheroids in the microwells exhibited perfectly spherical aggregation. In this report, by adjusting the size of the microwells of the TASCL device, uniform HepG2 spheroids were created, and the device facilitated more precise measurements of the liver function per HepG2 spheroid. Our TASCL device will be useful for application as a toxicity evaluation system for drug testing.

Entities:  

Keywords:  Human hepatocellular carcinoma (HepG2) cells; Medical evaluation; Spheroid; Tapered stencil for cluster culture (TASCL); Three-dimensional (3D) culture

Year:  2015        PMID: 26858908      PMCID: PMC4733911          DOI: 10.3727/215517915X689056

Source DB:  PubMed          Journal:  Cell Med        ISSN: 2155-1790


  24 in total

1.  Two-dimensional multiarray formation of hepatocyte spheroids on a microfabricated PEG-brush surface.

Authors:  Hidenori Otsuka; Akihiro Hirano; Yukio Nagasaki; Teruo Okano; Yasuhiro Horiike; Kazunori Kataoka
Journal:  Chembiochem       Date:  2004-06-07       Impact factor: 3.164

2.  An improvement in the attaching capability of cryopreserved human hepatocytes by a proteinaceous high molecule, sericin, in the serum-free solution.

Authors:  Yoshitaka Miyamoto; Naozumi Teramoto; Shuji Hayashi; Shin Enosawa
Journal:  Cell Transplant       Date:  2010-06-03       Impact factor: 4.064

Review 3.  Primary hepatocytes: current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies.

Authors:  Nicola J Hewitt; María José Gómez Lechón; J Brian Houston; David Hallifax; Hayley S Brown; Patrick Maurel; J Gerald Kenna; Lena Gustavsson; Christina Lohmann; Christian Skonberg; Andre Guillouzo; Gregor Tuschl; Albert P Li; Edward LeCluyse; Geny M M Groothuis; Jan G Hengstler
Journal:  Drug Metab Rev       Date:  2007       Impact factor: 4.518

4.  Preconditioned cell array optimized for a three-dimensional culture of hepatocytes.

Authors:  Yoshitaka Miyamoto; Takeshi Ikeya; Shin Enosawa
Journal:  Cell Transplant       Date:  2009       Impact factor: 4.064

Review 5.  Stem cells for hepatic regeneration: the role of adipose tissue derived mesenchymal stem cells.

Authors:  Tetsuya Ishikawa; Agnieszka Banas; Keitaro Hagiwara; Hideki Iwaguro; Takahiro Ochiya
Journal:  Curr Stem Cell Res Ther       Date:  2010-06       Impact factor: 3.828

6.  Cytochrome P450 3A4 mRNA is a more reliable marker than CYP3A4 activity for detecting pregnane X receptor-activated induction of drug-metabolizing enzymes.

Authors:  Odette A Fahmi; Mary Kish; Sherri Boldt; R Scott Obach
Journal:  Drug Metab Dispos       Date:  2010-06-21       Impact factor: 3.922

7.  Cryopreservation in situ of cell monolayers on collagen vitrigel membrane culture substrata: ready-to-use preparation of primary hepatocytes and ES cells.

Authors:  Yoshitaka Miyamoto; Shin Enosawa; Tomoyo Takeuchi; Toshiaki Takezawa
Journal:  Cell Transplant       Date:  2009       Impact factor: 4.064

8.  Technique for the control of spheroid diameter using microfabricated chips.

Authors:  Yusuke Sakai; Kohji Nakazawa
Journal:  Acta Biomater       Date:  2007-06-29       Impact factor: 8.947

9.  Differentiation and transplantation of human embryonic stem cell-derived hepatocytes.

Authors:  Hesham Basma; Alejandro Soto-Gutiérrez; Govardhana Rao Yannam; Liping Liu; Ryotaro Ito; Toshiyuki Yamamoto; Ewa Ellis; Steven D Carson; Shintaro Sato; Yong Chen; David Muirhead; Nalu Navarro-Alvarez; Ronald J Wong; Jayanta Roy-Chowdhury; Jeffrey L Platt; David F Mercer; John D Miller; Stephen C Strom; Naoya Kobayashi; Ira J Fox
Journal:  Gastroenterology       Date:  2008-10-29       Impact factor: 22.682

10.  Reproducible, ultra high-throughput formation of multicellular organization from single cell suspension-derived human embryonic stem cell aggregates.

Authors:  Mark D Ungrin; Chirag Joshi; Andra Nica; Céline Bauwens; Peter W Zandstra
Journal:  PLoS One       Date:  2008-02-13       Impact factor: 3.240

View more
  13 in total

1.  Advances in Engineered Human Liver Platforms for Drug Metabolism Studies.

Authors:  Gregory H Underhill; Salman R Khetani
Journal:  Drug Metab Dispos       Date:  2018-08-22       Impact factor: 3.922

Review 2.  Engineered Liver Platforms for Different Phases of Drug Development.

Authors:  Brenton R Ware; Salman R Khetani
Journal:  Trends Biotechnol       Date:  2016-09-02       Impact factor: 19.536

3.  Enhanced Adipogenic Differentiation of Human Adipose-Derived Stem Cells in an In Vitro Microenvironment: The Preparation of Adipose-Like Microtissues Using a Three-Dimensional Culture.

Authors:  Yoshitaka Miyamoto; Masashi Ikeuchi; Hirofumi Noguchi; Tohru Yagi; Shuji Hayashi
Journal:  Cell Med       Date:  2016-09-14

Review 4.  Advances in Engineered Liver Models for Investigating Drug-Induced Liver Injury.

Authors:  Christine Lin; Salman R Khetani
Journal:  Biomed Res Int       Date:  2016-09-20       Impact factor: 3.411

5.  The Microwell-mesh: A high-throughput 3D prostate cancer spheroid and drug-testing platform.

Authors:  E O Mosaad; K F Chambers; K Futrega; J A Clements; M R Doran
Journal:  Sci Rep       Date:  2018-01-10       Impact factor: 4.379

Review 6.  Bioengineered Liver Models for Drug Testing and Cell Differentiation Studies.

Authors:  Gregory H Underhill; Salman R Khetani
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2017-12-06

7.  Development of 3D Hepatic Constructs Within Polysaccharide-Based Scaffolds with Tunable Properties.

Authors:  Marie-Noëlle Labour; Camile Le Guilcher; Rachida Aid-Launais; Nour El Samad; Soraya Lanouar; Teresa Simon-Yarza; Didier Letourneur
Journal:  Int J Mol Sci       Date:  2020-05-21       Impact factor: 5.923

Review 8.  Engineered Liver-on-a-Chip Platform to Mimic Liver Functions and Its Biomedical Applications: A Review.

Authors:  Jiu Deng; Wenbo Wei; Zongzheng Chen; Bingcheng Lin; Weijie Zhao; Yong Luo; Xiuli Zhang
Journal:  Micromachines (Basel)       Date:  2019-10-07       Impact factor: 2.891

9.  Characterization of a functional C3A liver spheroid model.

Authors:  Harriet Gaskell; Parveen Sharma; Helen E Colley; Craig Murdoch; Dominic P Williams; Steven D Webb
Journal:  Toxicol Res (Camb)       Date:  2016-04-27       Impact factor: 3.524

10.  Development of a tunable method to generate various three-dimensional microstructures by replenishing macromolecules such as extracellular matrix components and polysaccharides.

Authors:  Fumiya Tao; Kanae Sayo; Kazuyuki Sugimoto; Shigehisa Aoki; Nobuhiko Kojima
Journal:  Sci Rep       Date:  2020-04-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.